Diabetic patients with COVID-19 given sitagliptin and insulin had a mortality rate of 18 percent compared with 37 percent in matched patients receiving only insulin, stated a new study.
from Medindia Health News https://ift.tt/3jmcrE0
Tuesday, 29 September 2020
Diabetes Drug Sitagliptin Boosts Survival in Diabetic Patients With COVID-19
Diabetic patients with COVID-19 given sitagliptin and insulin had a mortality rate of 18 percent compared with 37 percent in matched patients receiving only insulin, stated a new study.
from Medindia Health News https://ift.tt/3jmcrE0
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment